- Event: UBS Obesity Therapeutics Day
Location: Virtual
Date:Thursday, May 23, 2024
Time:12:00-12:30 PM ET
- Event:
Jefferies Global Healthcare Conference
Location:New York, NY
Date:Thursday, June 6, 2024
Time:11:00-11:25 AM ET
- Event: Goldman Sachs 45th Annual Global Healthcare Conference
Location:Miami, FL
Date:Tuesday, June 11, 2024
A webcast of the
About
Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift inflammation and immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral immunology therapies for peripheral and neuroinflammatory diseases. Ventyx is headquartered in
Investor Relations Contact
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com
Source:
2024 GlobeNewswire, Inc., source